-
Autophagy–Liver Metastasis Signature in CRC
2026-09-15
Bai et al. developed a six-gene prognostic signature that integrates autophagy and liver-metastasis biology in colorectal cancer using bulk and single-cell transcriptomic analyses. The model links higher risk with an immunosuppressive microenvironment, exhausted CD8+ T cells, SPP1+ M2-like macrophages, and possible resistance to immunotherapy, while also illustrating the limits of computational biomarker translation.
-
Biotin-tyramide for Reliable Cell Assay Imaging
2026-09-15
Learn how Biotin-tyramide (SKU A8011) can extend cell viability, proliferation, and cytotoxicity studies with spatially resolved endpoint labeling. This scenario-based guide covers mechanism, compatibility, solvent preparation, interpretation, and practical product-selection criteria for TSA workflows.
-
3D Organoid–Fibroblast Models of PDAC Resistance
2026-09-14
Schuth et al. developed a patient-specific three-dimensional co-culture system combining pancreatic ductal adenocarcinoma organoids with matched cancer-associated fibroblasts to model stromal effects on chemotherapy response. The study links fibroblast-mediated protection from drug-induced death with inflammatory fibroblast states and epithelial-to-mesenchymal transition-associated changes in tumor organoids, providing a framework for more physiologically relevant drug profiling.
-
Carbapenemase Transmission in CREC Hospitals
2026-09-14
Chen et al. (2025) mapped carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae collected from eight teaching hospitals in Guangdong during 2022–2024. The study combines gene localization, antimicrobial susceptibility testing, conjugation assays, mobile-element analysis, and strain typing to show that plasmid-associated blaNDM−1 and efficient horizontal transfer are central features of CREC dissemination.
-
Linoleic Acid C18:2 Workflow Guide
2026-09-13
Linoleic Acid (C18:2(9Z,12Z), SKU C3108) provides a defined omega-6 fatty acid input for studying lipid exposure, oxidative stress, membrane behavior, epithelial migration, and essential fatty acid biology. It is water-insoluble, requires a controlled ethanol or DMSO vehicle, and is best used with freshly prepared solutions rather than long-term aqueous or stored-stock workflows.
-
Z-YVAD-FMK: Caspase-1 Inhibitor Workflows
2026-09-12
Z-YVAD-FMK enables mechanism-focused studies of caspase-1, inflammasome signaling, and pyroptotic cell death without treating every loss of viability as apoptosis. This workflow guide connects practical dosing, gasdermin cleavage assays, cancer research, avian models, and troubleshooting for more defensible results.
-
AL-8810: FP Receptor Antagonist Workflows
2026-09-12
AL-8810 enables mechanism-focused experiments on PGF2α/PTGFR signaling, from rapid ERK1/2 assays to endometrial vascular remodeling models. This workflow-centered guide explains dose design, orthogonal readouts, storage, and troubleshooting for reproducible FP receptor antagonist research.
-
MMP-2 Responsive Liposomes for Breast Cancer Immunotherapy
2026-09-11
Chuan Hu and colleagues developed an MMP-2-responsive, dual-targeting liposome that sequentially delivers the PD-1/PD-L1 blockade peptide AUNP-12 and the IDO inhibitor NLG919. The study shows how cascade targeting can improve immune-microenvironment remodeling and antitumor activity in breast cancer models while reducing the limitations of conventional combination immunotherapy.
-
Quantifying Methylated Purine Nucleosides in Cells
2026-09-11
Zhang, Zhang, and Wang developed a stable isotope-diluted UHPLC–ESI-MS/MS method for accurately measuring 12 purine ribonucleosides, including 10 methylated species and difficult structural isomers. Its combination of ammonium bicarbonate-enhanced ionization, chromatographic resolution, and methanol–SPE cleanup improves sensitivity in cellular metabolomics and provides a useful framework for RNA modification nucleoside and purine metabolism studies.
-
How BicD and MAP7 Activate Drosophila Kinesin-1
2026-09-10
The reference study shows that BicD and MAP7 activate homodimeric Drosophila kinesin-1 through distinct but complementary mechanisms. BicD relieves kinesin autoinhibition, whereas full-length MAP7 improves motor engagement with microtubules; together, they produce the strongest activation in the reconstituted system.
-
Potassium Channels and Renal Blood Flow in Sepsis
2026-09-10
This study shows that ATP-sensitive and calcium-activated potassium channels influence renal vascular responses during experimental sepsis in a context-dependent manner. Although channel blockers alone did not alter renal blood flow, glibenclamide or iberiotoxin intensified the fall in flow produced by norepinephrine or phenylephrine in septic rats, highlighting a potential risk of combining channel blockade with vasopressor therapy.
-
NHS-Biotin for Nanobody and Protein Assays
2026-09-09
NHS-Biotin combines efficient amine-reactive labeling with a short spacer that is useful for antibody detection, protein enrichment, and intracellular assay development. Paired with the peptidisc-assisted nanobody clustering strategy, it provides an orthogonal way to compare monomeric and multimeric binders without treating labeling chemistry as the assembly mechanism.
-
CSBTA Pharmacokinetics in MASH: Enzyme-Transporter Insights
2026-09-09
This 2025 study shows that MASH-like pathology can substantially alter the exposure, liver distribution, and hepatocyte accumulation of Corydalis saxicola Bunting total alkaloids and their major constituents. By combining UHPLC-MS/MS pharmacokinetics with transporter, microsomal metabolism, and expression analyses, it links disease-related pharmacokinetic variability to CYP450s, Oatp1b2, P-glycoprotein, and PXR-associated regulation.
-
BOP Reagent for Peptide and Prodrug Workflows
2026-09-08
BOP reagent enables controlled carboxyl group activation for amide bond formation, phenyl ester preparation, and blocked amino acid derivative workflows. This guide translates those bench advantages into a practical synthetic and assay-planning framework inspired by a carrier-free, ROS-responsive triterpene prodrug strategy for oral squamous cell carcinoma research.
-
Gut–Brain Cholinergic Signaling in Seizure Control
2026-09-08
Jia et al. identify a gut–vagus–brain cholinergic circuit through which Bacteroides fragilis suppresses seizures in mouse models and shows efficacy in a randomized trial involving pediatric refractory epilepsy. The study connects microbial ecology, colonic ChAT-positive cells, vagal transmission, and seizure control, providing a mechanistic framework for microbiota-targeted epilepsy research.